it posted a net loss of $7.2 million in 2015
But following clinical trial results, liraglutide, sold under the name Saxenda, gained approval in 2017 as a weight loss medication for people with a BMI of 30 or higher or for people with a BMI of 27 and higher who also have a metabolic health condition
If you missed our introduction to the Miami-based innovators behind some of the industry's most trusted ingredients, catch up in the article linked above to understand the pharmaceutical-grade approach that's reshaping nutraceutical delivery systems
This medication is FDA-approved specifically for rare genetic obesity conditions including POMC, PCSK1, or LEPR deficiency and Bardet-Biedl syndrome
Eggs, Greek yogurt, fish, chicken, legumes (yes, they count for both fiber AND protein
A study published in the European Journal of Clinical Investigation found that glutathione supplementation can improve immune response in individuals with deficiencies, as well as in older people, whose immune function tends to decline with age